Medpage Today on MSN3d
Managing Primary Biliary Cholangitis Progression and SymptomsOnce clinical suspicion has been established for primary biliary cholangitis (PBC), the "serologic hallmark" of the ...
Medpage Today on MSN3d
Primary Biliary Cholangitis Incidence and Prevalence GrowingPrimary biliary cholangitis (PBC) has typically been considered a rare condition, with a pooled global estimated incidence of ...
Significant correlation shown between blood levels and symptom relief; TH104 was well tolerated with no unexpected ...
On Friday, Gilead Sciences, Inc. (NASDAQ:GILD) revealed data from a two-and-a-half-year interim analysis from the ongoing ...
Primary biliary cholangitis (PBC) may be rare, but its impact on women can be profound, leaving too many undiagnosed for ...
Ipsen presents three late-breaking presentations and eight abstracts across rare cholestatic liver disease portfolio at AASLD 2024Elafibranor was granted marketing authorisation for the treatment of ...
KDEV) today announces that its portfolio company Umecrine Cognition will present data from a recent interim analysis from an ongoing Phase 1b/2a clinical study of golexanolone in patients with Primary ...
INTEGRIS-PSC featured in an oral late breaker presentationSOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, ...
Gilead Sciences Inc. (GILD) announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback